PROPHECY.APP
"Do not despise prophecies, but test everything; hold fast what is good."
Saints, please help me build the best Prophecy App and Website in the World!

Become a Patron to Prophecy.app!

INDIA’S 'FIRST' INDIGENOUS COVID-19 VACCINE COVAXIN GETS APPROVAL FOR HUMAN CLINICAL TRIAL

The country's 'first' indigenous COVID-19 vaccine COVAXIN, developed by city-based Bharat Biotech in collaboration with ICMR and NIV, has got the nod for human clinical trials from the Drug Controller General of India, the company said on Monday. The Phase I and Phase II clinical trials of the vaccine for SARS-CoV-2, approved after pre-clinical studies demonstrated safety and immune response, would start across the country next month.

More from:   CRUX

Related topics:
    COVAXIN
    #COVAXIN
    COVACCINE
    VACCINE
    COVID

Back to:   PROPHECY.APP

Privacy Policy